chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mom states around 5PM 7MAR91 child started vomiting & had a fever; Hot to touch gave APAP this went on for 3 days; was alright for a few days & became ill again; called Hlth Dept; 11MAR91 advised to MD saw MD dx throat infection;
Metal taste in mouth after receiving the vaccine, headache, fatigue, Fever for 12 hours, dizziness
This spontaneous report as received from a consumer concerning his 67 year old wife. The patient was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX in September 2012. No other co-suspects were reported. No concomitant medications were reported. In September 2012, the patient experienced red rash at injection site. No treatment information was provided. The patient did not seek medical attention. No laboratory tests were performed. The outcome of red rash at injection site was reported as recovering/resolving. The relatedness for red rash at injection site was unknown for ZOSTAVAX. Additional information is not expected.
Per pt, black-blue at site of injection. She does not feel much pain now. Tell pt use hot/cold patches.
Low grade fever (99.5), body aches, chills, sleep disturbance, arm pain,
Started with welts 7/12/07 on leg (12:30 a.m.) spreading 7-13-07 all over (face, legs, body and arms), had fever for 2 days 3 days ago no fever now, not uncomfortable.
Within a few hours of shots got huge welts on chest, trunk and legs along with feeling of butterflies in mouth. Whole face swollen and lips/nose were 2x size, Hives persisted x 3 days- Benadryl 1 tsp PO at home x 2
On day 8 following my vaccination, I ran a fever of 101 for two- two and a half days. In the very early morning of the 3rd day I had difficulty getting a deep breath and made a visit to the ED.  I was given a number of tests and released when all tests showed negative results.
Patient received TdAP, MCV, HPV at completion of third shot, her head jerked back & seemed to faint. Then sat up and said she could not hear, was very upset.
Case number PHHY2011US63990 is an initial spontaneous report received from a health care professional on 14 Jul 2011. This report refers to a 17 year old male patient. He was vaccinated with MENVEO (batch number: A10051) intramuscularly on 12 Jul 2011. The patient received only the Men CYW-135 liquid component without reconstituting it with Men A lyophilized powder component. No adverse event was reported following this drug administration error.
Pt experienced fever, sore stomach no appetite for 72 hours. Sibling also caught the virus.
administered adjuvant without active component; administered adjuvant without active component; This case was reported by a physician via sales rep and described the occurrence of inappropriate preparation of medication in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient was administered the Shingrix adjuvant in unknown arm without the active component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up. This case was linked with case US2022051810, US2022051806, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022051810:Same reporter. US-GLAXOSMITHKLINE-US2022051806:Same reporter.
Approximately 24 hrs post adm, began having sore throat, fever (102 deg), body aches, R shoulder pain and sharp pains in lower spine.
Information has been received from a physician concerning a 15 year old female patient who in the Spring of 2008 was vaccinated with the third dose of GARDASIL. The physician reported that about one and a half months after the 3rd dose of GARDASIL, the patient had a severe abdominal pain. The patient also developed a mild rash on one side of the hips that radiated to the knees. The patient was seen by both her primary physician and gynecologist. On an unspecified date, the patient had a CT scan that was negative. The symptoms were diagnosed as idiopathic. Outcome was not reported. Additional information has been requested.
This spontaneous report was received from a Journalist refers to a female patients of unknown age. On an unknown date, the patients were vaccinated with GARDASIL (dose, route and lot # were not reported). On an unknown date, the patients experienced unspecified adverse effects that have left them wheelchair bound, after receiving GARDASIL. The outcome of unspecified adverse effects that have left them wheelchair bound was unknown. This is one report of several reports from the same source (MARRS # 1408USA001063). This case was considered medically significant due to patient disabling. Additional information has been requested.
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Hypotension-Severe, Systemic: Shakiness-Severe, Additional Details: Patient was lightheaded and fainted post vaccine. He was non responsive for a few seconds. 911 was called and EMS treated patient on site. Patient denied hosptial visit.
Information has been received from a lawyer concerning a 12 year old male pt who on 7/11/89 and 8/20/92 was vaccinated with a 1st and 2nd dose of MMRII and diphtheria (+) tetanus. It is alleged that the aforementioned vaccines were contaminated and adulterated with mercury based thimerosal. It is also alleged that the pt was 1st dx'd and discovered to have mercury poisoning and related severe mental, physical and neurological injuries less than 1 year from 8/21/01. Upon internal review, mercury poisoning with related severe mental, physical and neurological injuries was determined to be an "Other Important Medical Event". No further information is available.
Information has been received from a physician concerning a 10 year old female who on 25Jun1997 was vaccinated with a single 0.5ml dose of varicella virus vaccine live. On 05Jan04 it was reported that recently the pt broke out with chickenpox. Her body was covered with lesions, especially on her chest. Unspecified medical attention was sought and the patient was being treated with diphenhydramine (BENADRYL) and colloidal oatmeal bath (AVEENO). It was reported that the pt has not recovered. No product quality complaint was involved. It was also reported that another pt was vaccinated with a dose of varicella virus vaccine live and also developed chickenpox. Additional information has been requested.
left upper extremity, trapezius, and sternocleidomastoid myasthenia with 3/5 strength.  Able to oppose gravity but not resistance.
80 year old fully vaccinated with Pfizer vaccine in February 2021 admitted to the hospital from 9/17-9/23 with Covid-19 pneumonia
6 y/o female presents flu symptoms.  Symptoms started 3 days ago. Low grad fever has been on and off. Vomited x 1 on Monday night. Diarrhea since Monday. Bodyaches.   Developed a rash last night to bilateral hands- itching and hurting. No appetite.  Received 1st COVID vaccine Saturday.  Been using tylenol/ibuprofen and benadryl last night for rash.
Vertigo; haven't received the second one yet; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) and PRODUCT DOSE OMISSION ISSUE (haven't received the second one yet) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo) and PRODUCT DOSE OMISSION ISSUE (haven't received the second one yet). The patient was treated with MECLIZINE HYDROCHLORIDE at an unspecified dose and frequency. At the time of the report, VERTIGO (Vertigo) had not resolved and PRODUCT DOSE OMISSION ISSUE (haven't received the second one yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Significant Follow-up. Outcome for the event vertigo and contact information updated.
This spontaneous report as received from a certified medical assistant refers to an adult patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On unknown dates, the patient was inadvertently vaccinated with two pediatric doses of RECOMBIVAX HB injection (dose, route of administration, lot# and expiry date were not reported). There were no concomitant therapies reported. No adverse effect was reported. There was no product quality complaint involved. This is one of two reports received from the same reporter. Additional information has been requested.
Whole bodyredness; shaking; coldness; tachycardia; shortness of breath; heaviness in lower extremities; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Whole bodyredness), FEELING COLD (coldness), TACHYCARDIA (tachycardia), DYSPNOEA (shortness of breath) and LIMB DISCOMFORT (heaviness in lower extremities) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced ERYTHEMA (Whole bodyredness), FEELING COLD (coldness), TACHYCARDIA (tachycardia), DYSPNOEA (shortness of breath) and LIMB DISCOMFORT (heaviness in lower extremities). The patient was treated with ROSUVASTATIN CALCIUM (CRESTOR) at an unspecified dose and frequency; ALLOPURINOL at an unspecified dose and frequency and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Whole bodyredness), FEELING COLD (coldness), TACHYCARDIA (tachycardia), DYSPNOEA (shortness of breath) and LIMB DISCOMFORT (heaviness in lower extremities) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
Initial pain at injection site. Became worse overnight. 2 or 3 days post injection developed a rash that appears adjacent to injection site and appears to be shingles.
Hives occurring on face, torso, and extremities approximately 2 hours after vaccines were given. Patient was given OTC Benadryl with gradual resolution back to normal/baseline over next 4 days. Family reports no other new/unusual exposures or ingestion on that day.
12 hours after the inj had chills, myalgia, headache low grade fever and nausea. Developed pain in external genitalia, Had ulcerations with bruising on 1/9/21. (Lesions)
Pt called 10/15 to complain of flattened red itchy itch rash that started around 10/12-13/07 on tops of arms and has spread to abdomen & chest areas as well.  Has not been seen by usual health care provider yet but has appt later in the week.  Pt feels is related to flu shot though he gets them annually and has never had reaction before.
This spontaneous report as received from a medical assistant refers to unspecified patients of unknown age and gender. The patient's pertinent medical history, current conditions and concomitant medications were not reported. On an unknown date the patients were vaccinated with improperly stored VARIVAX (lot # L013824, expiry date: 21-APR-2017), which was stored at temperature -13.7 degree centigrade for a time frame of 56 hours. There was no previous temperature excursion reported. The call was not due to data logger. No adverse effects reported. There was no product quality complaint involved. This is one of the two reports received from the same reporter. Additional information has been requested.
patient c/o Nausea, vomiting diarrhea a few days after the shot, then around 6/15 developed rashes over arms, legs, lasting at least a month. skin punch biopsy done that showed erythema nodosum. Patient also shows drop in hemoglobin from 13 to 10. also ANA is positive now with 1:160 titer.
A non-serious spontaneous report of gave half the total dose of FLUMIST was received from a physician concerning a female child, subsequent to FLUMIST. The patient received FLUMIST on 06-Nov-2008. A physician reported that his office received a report of 31 children ranging in age from five to seven years of age who received half of the total dose of FLUMIST in one nostril. The other half was discarded. Three was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Additional information was received on 24-Nov-2008 that included the following: demographic data, date of vaccination and confirmation that none of the children experienced adverse events.
12 hours after receiving that dose I had chills, fever, headache, body aches all over, I felt like someone put concrete blocks on my legs, woozy in the head, by day three the red swollen hot raised rash started the rash lasted a couple of weeks.
Inappropriate Reconstitution Technique; Inappropriate dose of vaccine administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 74-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number DA5C3, expiry date 09-MAY-2026) for prophylaxis.   On 02-OCT-2023, the patient received Arexvy. On 02-OCT-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: Inappropriate Reconstitution Technique) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 03-OCT-2023 The vaccine administration facility was the same as primary reporter The pharmacist stated that only the adjuvant portion of Arexvy was administered to a patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up via postal.
swelling pt reports aches and pains that he usually does not have since getting the Covid Booster shot 11/4/21. His hands have been swelling, and are more puffy in the AM. He is unsteady in the AM when he gets up, but reports no swelling or change in sensation of his feet.  No fever reports, but on occasion he has felt chills. Hand weakness noted (grip strength). The symptoms started in the L shoulder (the site of the vaccine admin). Then both his hands ached. Swelling occurred later. Symptoms tend to be worse in the AM, however, symptoms have awakened him at night.
Pt exposed to positive pt.  Pt tested and was positive today. Symptoms body ache, allergies,
Noticed area 8" long and 7' wide on underside of left upper arm with area of hardness approximately 5" long and 2" wide day following a sc Zostavax vaccine. Reddened and itches.
12 days, after YF vaccination, became "acutely ill" with pain in muscles throughout body and extreme weakness. Seen in ER. IV fluids given. Platlets 119. Electrolytes and glucose normal. Dx: "allergic reaction".
I saw him through the  window and patient was felling little dizzy so I step  outside  of pharmacy to patient waiting area and ask him how he was feeling . He couldn't  speak English and had the sister translate  to ask him how he was feeling  and the sister said he was nervous and  feeling dizzy . I checked his heart rate and berating,  notice  his heart rate was high . He was having a anxiety attack and palpitation . we called 911 and also  I gave a bottle of water to him , he drank some water  and started feeling better ,then ems came and they took over from there.
After typical soreness from flu vaccine resolved in 1-2 days, shoulder discomfort persisted in the joint area and continued to worsen.  Discomfort and pain continues when using shoulder for everyday activities.
Patient reports they "reacted horribly to covid shots" including dry heaves, chest pain and headaches
Red area on arm 10cm x 10cm where injection given. Warm compresses used. No treatment needed. Cleared on own.
Left forearm hurt. The next day, the bicept started to hurt. The next day left side of back became sensitive. Today, Saturday, one week after injection hives on left arm (arm which received injection) and on left side of chest.
Started with a small area of redness and expanded to a larger area of redness and swelling (4 inch by 3 inch approx).
Red, hot quarter size area hard. Next day eccomytic, pain to site and arm. Reported 5/27 2.5 cm eccomotic area present. Arm OK now.
Pt was due for Menveo vaccine and received a Trumenba Men B vaccine in error.
12/06/2006 pt complained of lingering pain at injection site to me on 12/06/06, injection given 11/15/06. Patient with discomfort at date 12/06/2006.
Certified Technician administered the vaccine to patient in the administration cubicle in front of the pharmacy.  As he was administering the vaccine, some of the vaccine leaked out/sprayed out from the point at which the needle is attached to the syringe. Most of the vaccine was administered. The syringe used was a 1ml VanishPoint syringe, it comes with the needle already attached to it, the needle is non-removable but retractable. We pulled the rest of the syringes from that box and hazwasted them as a precaution/prevention for this happening again. Per CDC, since more than half of the dose was administered, we did not repeat the dose.
Initial unsolicited report received from a healthcare professional on 01 November 2016. This case involves a 69-year-old female patient who was vaccinated with a Fluzone HD (batch number: UI654AE, expiry date: 07-APR-2017, dose, dose in series and route of administration were not reported) in the left deltoid on 25 October 2016. The patient denied any medical issues and any known allergies. No other information about the patient's medical history was reported. Concomitant medications were reported as unknown. On 25 October 2016, the night of vaccination (time unspecified), the patient had swelling at the injection site, chills and tachycardia. The patient needed ER visit. Lab data was not reported. The patient received corrective treatment with Zyrtec and hydrocortisone cream. The outcome of the events was not recovered. List of documents held by sender: none.
Fever of 101 starting 14 hours after injection and fever 99-101 lasting 26 hours. Bruise and pain at site of injection
My COVID-19 symptoms started on 01/16/2023 in the morning. I had chest congestions, and stuffy nose. It was like a cold. I slept 2 hours straight that day. I went to the doctor's office on the 01/20/2023 and I was notified on the 01/21/2023 that I tested positive. They advised me to double of on my vitamins such as vitamin D, drink plenty of fluids and (4) 50mg of zinc. Within 2 and half weeks I fully recovered.
Subacute myalgias, numbness, neuropathic pain, possible GBS variant. Began 2-3 weeks after receiving vaccine. Progressed over 2 weeks, then stable for last few months. Nerve conduction studies pending.
Employee stated she felt dizzy shortly after receiving vaccine. Assessed by RN and EMT's and rested for 30 minutes then went home.
Mom noticed left arm swelling, redness from shoulder down to elbow. Some soreness in arm as well.Swelling is more on upper arm.
Pain in joints, depression, dry mouth, endurance loss, abdomen burning sensation, cramps, impatience, acid reflux, feel sluggish at times, cold and flu-like symptoms.
received only diluent component; received only diluent component; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number 7XC23, expiry date 12th October 2023) for prophylaxis.   On 21st September 2022, the patient received the 1st dose of Shingrix. On 21st September 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 26-SEP-2022 Reporter's Comments: The medical assistant called and reported that a female patient received only the diluent component of Shingrix. The vaccine administration facility was the same as primary reporter. The reporter consent to follow up. Additional Supportive Information: The patients received Shingrix vaccines with only the diluent component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
This spontaneous report was received from a other reporter, only two doses of VARIVAX (Merck) were used on two patients. This case refers to a 4 year old female patient. On 06-NOV-2015 at 10 AM, the patient was vaccinated with first dose of improperly stored dose of VARIVAX (Merck) lot # K005428, expiry date 15-APR-2016, in the right leg (thigh), at private doctor's office using private funds. Other vaccines given within four weeks were PENTACEL, lot # C4877AA, fourth dose, in the left thigh, on 06-NOV-2015 at 10 AM; PREVENAR 13, lot # L99262, third dose, in the left thigh, on 06-NOV-2015 at 10 AM; Hepatitis A virus vaccine (unspecified), lot # L023936, first dose, in the left thigh, on 06-NOV-2015 at 10 AM; influenza virus vaccine (unspecified), lot # UI450AD, second dose, in the right thigh, on 06-NOV-2015 at 10 AM; and M-M-R II, lot # K005431, first dose, in the right thigh, on 06-NOV-2015 at 10 AM. This is one of three reports received from the same reporter. Additional information has been requested.
Extreme Tiredness, no strength, worn out, cannot perform normal activities an my normal level.  Continuing since vaccine Headache
migraine; This is a spontaneous report from a contactable consumer. An adult male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced migraine that has lasted for almost one week since receiving the vaccine. The reporter did not know if the vaccine that the patient received was from Pfizer or Moderna. Outcome of event was unknown.  Information on lot/batch number has been requested.
Pt recvd 1st dose of HIB on 4MAR91 & on 23MAR91 devel meningitis  & exp was considered life-threatening; no further details were provided;